Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions
暂无分享,去创建一个
Sung Hoon Kim | Daniel Henrion | Pierre Chambon | Philip W Shaul | P. Chambon | J. Katzenellenbogen | F. Lenfant | A. Krust | A. Fabre | P. Shaul | J. Arnal | D. Henrion | M. Adlanmerini | C. Fontaine | P. Gourdy | A. Abot | Sung Hoon Kim | F. Boudou | John A Katzenellenbogen | P. Liere | A. Guihot | I. Raymond-Letron | Aurélie Fabre | Isabelle Raymond-Letron | Coralie Fontaine | Jean-François Arnal | Pierre Gourdy | Andrée Krust | Anne-Laure Guihot | Françoise Lenfant | Marine Adlanmerini | Romain Solinhac | Anne Abot | Frédéric Boudou | Lucile Sautier | Emilie Vessières | Philippe Lière | E. Vessières | R. Solinhac | Lucile Sautier | Frédéric Boudou | Marine Adlanmerini
[1] E. Levin,et al. Integration of the extranuclear and nuclear actions of estrogen. , 2005, Molecular endocrinology.
[2] E. Levin,et al. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. , 2000, Molecular endocrinology.
[3] K. Korach,et al. Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators , 2011, Proceedings of the National Academy of Sciences.
[4] Konrad F. Koehler,et al. Development of subtype-selective oestrogen receptor-based therapeutics , 2011, Nature Reviews Drug Discovery.
[5] B. Mouillac,et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.
[6] G. Leclercq,et al. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity. , 2012, Molecular endocrinology.
[7] M. Schumacher,et al. Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[8] P. Chambon,et al. The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol , 2009, Proceedings of the National Academy of Sciences.
[9] H. Witkowska,et al. Carboxymethylation of the human estrogen receptor ligand-binding domain-estradiol complex: HPLC/ESMS peptide mapping shows that cysteine 447 does not react with iodoacetic acid , 1996, Steroids.
[10] C. Rosenfeld,et al. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. , 1997, The American journal of physiology.
[11] E. Levin,et al. Developmental Phenotype of a Membrane Only Estrogen Receptor α (MOER) Mouse* , 2009, Journal of Biological Chemistry.
[12] A. Quyyumi,et al. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.
[13] G. Kassab,et al. Estrogen Induces Vascular Wall Dilation , 2005, Journal of Biological Chemistry.
[14] R. Pietras,et al. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells , 1977, Nature.
[15] C. Mineo,et al. Non-nuclear Estrogen Receptor Signaling in the Endothelium* , 2011, The Journal of Biological Chemistry.
[16] Cory C. Funk,et al. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. , 2006, Molecular endocrinology.
[17] J. Greaves,et al. The intracellular dynamic of protein palmitoylation , 2010, The Journal of cell biology.
[18] I. Treilleux,et al. Activation of rapid oestrogen signalling in aggressive human breast cancers , 2012, EMBO molecular medicine.
[19] F. Lenfant,et al. Key Role of Estrogens and Endothelial Estrogen Receptor &agr; in Blood Flow–Mediated Remodeling of Resistance Arteries , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[20] S. Hammes,et al. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. , 2007, Annual review of physiology.
[21] K. Ley,et al. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.
[22] F. Ebling,et al. Methods for quantifying follicular numbers within the mouse ovary. , 2004, Reproduction.
[23] J. Katzenellenbogen,et al. Probing conformational changes in the estrogen receptor: evidence for a partially unfolded intermediate facilitating ligand binding and release. , 2001, Molecular endocrinology.
[24] P. Chambon,et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.
[25] P. Visca,et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. , 2005, Molecular biology of the cell.
[26] B. Katzenellenbogen,et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. , 2010, The Journal of clinical investigation.
[27] R. Karas,et al. Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system , 2013, Steroids.
[28] F. Stossi,et al. Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs , 2010, Molecular and Cellular Biology.
[29] G. Garcı́a-Cardeña,et al. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.
[30] T. Simoncini. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging , 2009, Climacteric : the journal of the International Menopause Society.
[31] J. Bender,et al. Membrane-initiated actions of estrogen on the endothelium , 2009, Molecular and Cellular Endocrinology.
[32] R. Sainson,et al. A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane* , 2007, Journal of Biological Chemistry.
[33] R. Campbell,et al. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. , 2013, Endocrinology.
[34] P. Chambon,et al. Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing , 2011, Proceedings of the National Academy of Sciences.
[35] K. Korach,et al. Lessons in estrogen biology from knockout and transgenic animals. , 2005, Annual review of physiology.
[36] D. Friend,et al. HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, The Journal of cell biology.
[37] J. Davis,et al. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[38] E. Levin,et al. Minireview: Recent Advances in Extranuclear Steroid Receptor Actions , 2011, Endocrinology.
[39] Qing Lu,et al. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] G. Kassab,et al. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. , 2005, The Journal of biological chemistry.
[41] F. Lenfant,et al. The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo. , 2013, Endocrinology.
[42] C. Mineo,et al. Coupling of Fc&ggr; Receptor I to Fc&ggr; Receptor IIB by Src Kinase Mediates C-Reactive Protein Impairment of Endothelial Function , 2011, Circulation research.
[43] P. Chambon,et al. The transactivating function-1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17 beta-estradiol. , 2009 .
[44] B. Komm,et al. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. , 2008, Molecular endocrinology.
[45] B. O’Malley,et al. Nuclear receptor coregulators: modulators of pathology and therapeutic targets , 2012, Nature Reviews Endocrinology.
[46] L. Björnström,et al. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. , 2002, Molecular endocrinology.
[47] Rakesh Kumar,et al. Signaling regulation of genomic and nongenomic functions of estrogen receptors. , 2006, Cancer letters.
[48] Richard G. W. Anderson,et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. , 2000, Circulation research.